Home › Funds › DRIEHAUS CAPITAL MANAGEMENT LLC › EWTX
DRIEHAUS CAPITAL MANAGEMENT LLC position in EWTX
EDGEWISE THERAPEUTICS INC · Health Care
DRIEHAUS CAPITAL MANAGEMENT LLC reported holding 4,401,906 shares of EWTX (EDGEWISE THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$178.7M, representing 1.24% of its reported portfolio and ranking #8 among its reported holdings. DRIEHAUS CAPITAL MANAGEMENT LLC has disclosed EWTX holdings in 12 of the last 12 reported quarters, going back to Q4 2023.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How DRIEHAUS CAPITAL MANAGEMENT LLC's EWTX position evolved
DRIEHAUS CAPITAL MANAGEMENT LLC first disclosed a stake in EWTX in Q4 2023 at 395,069 shares (US$4.3M). The position peaked in Q2 2026 at 4,728,623 shares, worth US$192.1M. Across 12 filings, DRIEHAUS CAPITAL MANAGEMENT LLC increased the stake 7 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 4,401,906 shares valued at US$178.7M — a reduction of -326,717 shares quarter over quarter.. Notable position changes include a 221% increase in Q1 2024 (shares fell 1% over the following quarter), a 55% increase in Q3 2024 (shares were roughly flat over the following quarter), a 88% increase in Q4 2025 (shares rose 27% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 395.07K | $4.32M | New |
| Q1 2024 | 1.27M | $23.13M | Add |
| Q2 2024 | 1.26M | $22.70M | Reduce |
| Q3 2024 | 1.95M | $52.14M | Add |
| Q4 2024 | 1.49M | $39.88M | Reduce |
| Q1 2025 | 1.38M | $30.27M | Reduce |
| Q2 2025 | 2.10M | $27.55M | Add |
| Q3 2025 | 2.23M | $36.14M | Add |
| Q4 2025 | 4.19M | $104.00M | Add |
| Q1 2026 | 4.48M | $141.06M | Add |
| Q2 2026 | 4.73M | $192.12M | Add |
| Q3 2026 | 4.40M | $178.72M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About EWTX and 13F data
EWTX (EDGEWISE THERAPEUTICS INC) is a Health Care company. 42 other funds we track also report a position in EWTX — the largest reported positions include ORBIMED ADVISORS LLC (US$630.5M), Paradigm Biocapital Advisors LP (US$437.6M), RA CAPITAL MANAGEMENT, L.P. (US$341.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding EWTX
- ORBIMED ADVISORS LLC 15.52M sh · $630.52M · Q2 2026
- Paradigm Biocapital Advisors LP 10.78M sh · $437.61M · Q3 2026
- RA CAPITAL MANAGEMENT, L.P. 8.39M sh · $341.00M · Q2 2026
- Novo Holdings A/S 5.35M sh · $217.37M · Q2 2026
- PERCEPTIVE ADVISORS LLC 4.37M sh · $177.71M · Q2 2026
- BAKER BROS. ADVISORS LP 3.70M sh · $150.40M · Q2 2026
- Siren, L.L.C. 2.80M sh · $113.85M · Q3 2026
- Cormorant Asset Management, LP 2.51M sh · $101.98M · Q2 2026
- BRAIDWELL LP 2.00M sh · $81.14M · Q2 2026
- MPM BioImpact LLC 1.62M sh · $65.85M · Q2 2026
- Deep Track Capital, LP 1.15M sh · $46.64M · Q3 2026
- First Light Asset Management, LLC 1.10M sh · $44.50M · Q2 2026
More on DRIEHAUS CAPITAL MANAGEMENT LLC
FAQ
How long has DRIEHAUS CAPITAL MANAGEMENT LLC held EWTX?
DRIEHAUS CAPITAL MANAGEMENT LLC has disclosed EWTX holdings in 12 of the last 12 reported quarters, going back to Q4 2023.
What is DRIEHAUS CAPITAL MANAGEMENT LLC's current position in EWTX?
As of Q3 2026, DRIEHAUS CAPITAL MANAGEMENT LLC holds 4.40M shares of EWTX (EDGEWISE THERAPEUTICS INC), valued at $178.72M, representing 1.24% of its reported portfolio and ranking #8.
Has DRIEHAUS CAPITAL MANAGEMENT LLC been buying or selling EWTX?
In the latest 13F filing (Q3 2026), DRIEHAUS CAPITAL MANAGEMENT LLC reduced its position in EWTX. The position peaked in Q2 2026 at 4.73M shares.
Which other funds hold EWTX?
Other major institutional holders of EWTX include ORBIMED ADVISORS LLC, Paradigm Biocapital Advisors LP, RA CAPITAL MANAGEMENT, L.P., among 42 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.